Search Results - Bahadur, Shakeela W

  • Showing 1 - 3 results of 3
Refine Results
  1. 1
    Immunotherapy for the Treatment of Breast Cancer: Emerging New Data

    Immunotherapy for the Treatment of Breast Cancer: Emerging New Data by Mina, Lida A, Lim, Shannon, Bahadur, Shakeela W, Firoz, Abdul T

    Get full text
    Items that cite this one
    Article
    Save to List
    Saved in:
  2. 2
    Abstract P1-18-04: Phase 3 SOPHIA study of margetuximab + chemotherapy vs trastuzumab + chemotherapy in patients with HER2+ metastatic breast cancer after prior anti-HER2 therapies: Infusion time substudy results

    Abstract P1-18-04: Phase 3 SOPHIA study of margetuximab + chemotherapy vs trastuzumab + chemotherapy in patients with HER2+ metastatic breast cancer after prior anti-HER2 therapies... by Gradishar, William J., Im, Seock-Ah, Cardoso, Fatima, Cortes, Javier, Curigliano, Giuseppe, Pegram, Mark D., Musolino, Antonino, Berardi, Rosanna, De Laurentiis, Michelino, Bahadur, Shakeela W., Im, Young-Hyuck, Lynch, Cynthia, Novik, Yelena, Edlich, Sutton, Rock, Edwin, Hong, Shengyan, Rugo, Hope S.

    Get full text
    Article
    Save to List
    Saved in:
  3. 3
    Abstract PS10-24: Infusion related reactions in the phase 3 SOPHIA trial of margetuximab + chemotherapy vs trastuzumab + chemotherapy in patients with pretreated HER2+ metastatic breast cancer

    Abstract PS10-24: Infusion related reactions in the phase 3 SOPHIA trial of margetuximab + chemotherapy vs trastuzumab + chemotherapy in patients with pretreated HER2+ metastatic b... by Cortes, Javier, Cardoso, Fatima, Curigliano, Giuseppe, Gradishar, William J, Im, Seock-Ah, Rugo, Hope S, Bahadur, Shakeela W, Falcone, Alfredo, Murillo, Serafin Morales, Riseberg, David A, Musolino, Antonino, Feinstein, Trevor M, Abreu, Miguel H, Im, Young-Hyuck, Novik, Yelena, Pluard, Timothy, Salazar, Lupe G, Berardi, Rossana, Pop, Viorela, Hong, Shengyan, Jacobs, Kenneth, Rock, Edwin, Pegram, Mark D

    Get full text
    Article
    Save to List
    Saved in:

Search Tools: